95
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Expanding of ST11 Carbapenemase-Producing Klebsiella pneumoniae Subclones in a Chinese Hospital, Shenzhen, China

, , , , , , , , , , , , ORCID Icon, , & ORCID Icon show all
Pages 1415-1422 | Published online: 13 Apr 2021
 

Abstract

Background

ST11 is the most prevalent sequence type of clinical Klebsiella pneumoniae in China.

Methods

We investigated the characteristics of the ST11 subclones using core genome multi-locus sequence typing (cgMLST). Ninety-three carbapenemase-producing K. pneumoniae isolates were collected at Shenzhen People’s Hospital. Then, whole-genome sequencing and cgMLST were used to discriminate apparent subclones within the ST11 group.

Results

We analyzed the prevalence and genetic relationships of these subclones. ST11 and K. pneumoniae carbapenemase (KPC-2) were the predominant genotype and carbapenemase, respectively, in the clinical carbapenemase-producing K. pneumoniae strains. cgMLST scheme genotyping divided the ST11 group into two clades across seven complex types (CTs). CT1313 was the most prevalent subclone. The deletion of galF and a high frequency of SNPs in genes associated with the stress- and SOS-responses were found in CT1291 and CT2405 over time, respectively.

Conclusion

Our results indicated that the subclones of the ST11 group had different patterns of prevalence. Highly discriminatory genotyping techniques, such as cgMLST scheme, should be used in further molecular epidemiology investigations.

Data Sharing Statement

The genome sequences were deposited in the GenBank, under BioProject PRJNA517992.

Ethics Statement

This study was conducted in accordance with the Declaration of Helsinki. The research protocol was approved by the research ethics committee of Shenzhen People’s Hospital (reference 257 number LL-KY-2019002). The research ethics committee of Shenzhen People’s Hospital did not require written informed consent from participants because no personal information about patients was requested.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

The authors state that they have no conflicts of interest.